• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

SPDR S&P Biotech ETF

+ Add to Watchlist

XBI:US

198.5900 USD 2.1100 1.07%

As of 20:04:04 ET on 01/23/2015.

Snapshot for SPDR S&P Biotech ETF (XBI)

Open: 196.6800 High - Low: 199.2500 - 195.9400 Primary Exchange: NYSE Arca
Volume: 552,758 52-Week Range: 115.3117 - 201.7099 Beta vs SPSIBITR: 0.9990

ETF Chart for XBI

No chart data available.
  • XBI:US 198.5900
  • 1D
  • 1M
  • 1Y
196.4800
Interactive XBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for XBI

SPDR S&P Biotech ETF is an exchange-traded fund incorporated in the USA. The Fund seeks to replicate the performance of the S&P Biotechnology Select Industry Index, an equal-weighed index. The Index tracks all the US common stocks listed on the NYSE, American Stock Exchange, NASDAQ National Market and NASDAQ Small Cap exchanges.

Inception Date: 2006-02-06 Telephone: 1-866-787-2257
Managers: JOHN A TUCKER / MICHAEL FEEHILY
Web Site: www.spdrs.com

Fundamentals for XBI

NAV (on 2015-01-23) 198.4992
Assets (M) (on 2015-01-23) 1,677.3190
Shares out (M) 8.45
Market Cap (M) 1,678.09
% Premium 0.05
Average 52-Week % Premium -0.0031
Fund Leveraged N

Dividends for XBI

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2014-12-19) 0.4910
Dividend Yield (ttm) 1.01%

Performance for XBI

1-Month +10.83% 1-Year +26.09%
3-Month +20.44% 3-Year +40.55%
Year To Date +6.51% 5-Year +29.63%
Expense Ratio 0.35

Top Fund Holdings for XBI

Filing Date: 01/23/2015
Name Position Value % of Total
Foundation Medicine Inc 789,936 37,893,230 2.259%
Halozyme Therapeutics Inc 2,320,617 32,186,958 1.919%
NPS Pharmaceuticals Inc 592,805 27,055,620 1.613%
Neurocrine Biosciences Inc 843,983 26,754,261 1.595%
OPKO Health Inc 2,266,655 24,570,540 1.465%
Synageva BioPharma Corp 203,162 24,153,930 1.440%
Alkermes PLC 340,804 23,791,527 1.418%
Novavax Inc 3,218,978 23,723,868 1.414%
Celldex Therapeutics Inc 1,028,331 23,394,530 1.395%
Ultragenyx Pharmaceutical Inc 446,955 23,335,521 1.391%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil